Share Twitter LinkedIn Facebook Email Dr. Jack West reviews the trial design, key results, and implications of the CheckMate-331 trial of nivolumab (Opdivo) vs. standard chemotherapy for relapsed small cell lung cancer.
HARPOON THERAPEUTICS: New data on HPN328 T cell engager at ESMO 2023 Small Cell Lung Cancer 2 Mins Read
Emerging Treatment for SCLC – Leading Developments & Current Questions in Lung Cancer Small Cell Lung Cancer 1 Min Read
CAR T-Cell Therapy: Promising Results Against Small Cell Lung Cancer Renier Brentjens MD Small Cell Lung Cancer 1 Min Read